Dr. Vincent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Dept Of Medicine, Cb# 7005
Chapel Hill, NC 27514Phone+1 919-966-1072Fax+1 919-843-2356
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2013 - 2016- University of North Carolina HospitalsResidency, Internal Medicine, 2009 - 2013
University of North Carolina at Chapel Hill School of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2009 - 2025- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Tarlatamab for Large Cell Neuroendocrine Carcinoma in a Young Adult: A Case Report.Shetal A Patel, Young Whang, Chaely Medley, Kevin Chen, Jasmine Jordan
JTO Clinical and Research Reports. 2024-10-01 - 4 citationsImmune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P Vensko, Mark G Woodcock
Nature Communications. 2024-05-24 - 3 citationsAnti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30lymphoma: a phase 1 study.Natalie S Grover, George Hucks, Marcie L Riches, Anastasia Ivanova, Dominic T Moore
The Lancet. Haematology. 2024-05-01
Journal Articles
- Endogenous Retrovirus Expression Is Associated with Response to Immune Checkpoint Blockade in Clear Cell Renal Cell CarcinomaBenjamin G. Vincent, Jonathan S. Serody, Gregory Riedlinger, Shridar Ganesan, The Journal of Clinical Investigation
- Lifelong CMV Infection Improves Immune Defense in Old Mice by Broadening the Mobilized TCR Repertoire Against Third-Party InfectionBenjamin Vincent, MD, Proceedings of the National Academy of Sciences
Abstracts/Posters
- Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (_6...Benjamin G. Vincent, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- HLAProfiler Utilizes K-mer Profiles to Improve HLA Calling Accuracy for Rare and Common Alleles in RNA-Seq DataBenjamin Vincent, MD, BioMed Central, Orlando, FL, 12/9/2019
Press Mentions
2022 International Cancer Immunotherapy Conference Highlights from Day 4October 2nd, 2022- The Central Valley Has a Doctor Shortage. Kaiser and UC Davis Are Working to Change ThatApril 18th, 2022
- Newsworthy from the School of Medicine, Week of August 12 – 19August 18th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
